New alternatives for lowering clinical development costs of pharmaceutical/biotechnology products

Founded in 1995 by a biologist, a biometrician and a computer science specialist, Cardinal Systems provides Pharmaceutical/Biotech companies with new alternatives for lowering the cost of clinical development. Our use of optimal methods and technologies together with the advice given on innovative trial designs (adaptive) have been well received by our clients resulting in increasingly positive company turnover.

From technology management to eCTD

Providing a wide range of services (from centralised randomisation to ICH E3 reports and eCTD), and with an IT system which was developed to support and facilitate monitoring activities (technology management), Cardinal Systems offers original solutions for carrying out clinical trials and submitting new products.

The most efficient clinical trial data flow is chosen with the client. The clinical resources are then defined and our extranet aggregates information (from on-site/delocalised CRAs/nurses) which is then summarised for the sponsor.

Trial design and analysis plans are key points in the development process. Our varied experience in applied clinical trial statistics, flexible designs (adaptive/sequential) and regulatory affairs permits us to help clients successfully plan and analyse their clinical trials.

Strategic human resources management

A scientific company which reinvests in research and development is in itself attractive. Furthermore, Cardinal Systems' human resources policy (see employment opportunities section for further details) was put in place to stabilise resources.